NEETPGAI
FeaturesNEET PGFMGEINI-CETBlogPricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Features
  • Subjects
  • Previous Year Questions
  • NEET PG Preparation
  • FMGE Preparation
  • INI-CET Preparation
  • Compare
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Contact & support

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    Subjects/Pathology/COPD Pathology
    COPD Pathology
    hard
    microscope Pathology

    A 58-year-old Indian male smoker (35 pack-years) with COPD presents to the respiratory clinic with worsening dyspnea and a productive cough. Spirometry shows FEV₁ 38% predicted with a post-bronchodilator FEV₁/FVC of 0.52. Chest X-ray reveals hyperinflation with flattened diaphragms. A lung biopsy specimen is examined under the microscope and shows chronic inflammation with infiltration of CD8+ T lymphocytes, macrophages, and neutrophils in the small airways and parenchyma. Additionally, there is evidence of oxidative stress with increased reactive oxygen species (ROS) and reduced antioxidant defenses. Which of the following best explains the mechanism of progressive airway destruction in this patient's COPD?

    A. Protease-antiprotease imbalance with neutrophil elastase and matrix metalloproteinases overwhelming antioxidant and antiprotease defenses
    B. Th1-mediated granulomatous inflammation with epithelioid histiocytes and caseating necrosis
    C. Th2-mediated allergic inflammation leading to eosinophil recruitment and IgE-mediated mast cell degranulation
    D. Immune complex deposition in the alveolar basement membrane triggering complement-mediated tissue injury

    Explanation

    Pathophysiology of Progressive Airway Destruction in COPD

    Key Point
    The central mechanism driving COPD pathology is a protease-antiprotease imbalance amplified by oxidative stress, leading to progressive destruction of elastic fibers and alveolar walls.
    The Protease-Antiprotease Hypothesis

    This is the foundational model of COPD pathophysiology, supported by decades of research and clinical evidence:

    1. Source of Proteases

    Cigarette smoke activates and recruits inflammatory cells that release proteolytic enzymes:

    Table
    ProteaseSourceTargetEffect
    Neutrophil elastase (NE)NeutrophilsElastin in alveolar wallsLoss of elastic recoil
    Matrix metalloproteinases (MMP-2, MMP-9)Macrophages, neutrophilsCollagen, elastin, proteoglycansStructural breakdown
    Cathepsin LMacrophagesElastin, collagenParenchymal destruction
    2. Antiprotease Defenses — Now Overwhelmed

    Normally, the lung has protective antiprotease mechanisms:

    • α₁-antitrypsin (α₁-AT) — inhibits neutrophil elastase
    • Tissue inhibitors of metalloproteinases (TIMPs) — inhibit MMPs
    • Secretory leukocyte protease inhibitor (SLPI) — broad-spectrum protease inhibitor

    Critical point: In COPD, these defenses are:

    1. 1.
      Quantitatively overwhelmed — proteases vastly exceed antiprotease capacity
    2. 2.
      Functionally impaired — oxidative stress inactivates α₁-AT and other inhibitors
    3. 3.
      Chronically activated — persistent inflammation maintains protease production
    High-YieldNEET PG
    The protease-antiprotease imbalance explains why COPD is progressive and irreversible — once elastin is destroyed, it cannot be regenerated.
    Oxidative Stress — The Amplifier

    Cigarette smoke is a direct source of ROS, and inflammatory cells generate additional ROS through NADPH oxidase and mitochondrial sources:

    Loading diagram...
    Key Point
    Oxidative stress:
    • Inactivates α₁-AT — the primary defense against neutrophil elastase
    • Damages antioxidant enzymes — superoxide dismutase (SOD), catalase, glutathione peroxidase
    • Perpetuates inflammation — ROS activate NF-κB, increasing cytokine production
    • Causes direct tissue injury — lipid peroxidation of cell membranes
    Histological Findings in This Case

    The biopsy shows the expected inflammatory infiltrate:

    Table
    Cell TypeRole in COPD
    CD8+ T lymphocytesOrchestrate chronic inflammation; produce IFN-γ and TNF-α
    MacrophagesRelease MMP-9, TNF-α, IL-6; generate ROS
    NeutrophilsRelease elastase, collagenase; amplify inflammation
    Clinical Pearl
    The predominance of CD8+ T cells (not CD4+) in COPD distinguishes it from asthma, which is typically CD4+ Th2-mediated. This reflects the chronic, cell-mediated nature of COPD.
    Why This Leads to Progressive Airway Destruction
    1. 1.
      Elastic fiber loss → loss of elastic recoil → air trapping and hyperinflation
    2. 2.
      Collagen degradation → weakening of airway walls → dynamic compression during expiration
    3. 3.
      Mucous gland hypertrophy (from chronic inflammation) → excessive mucus production → airway plugging
    4. 4.
      Smooth muscle dysfunction → increased airway reactivity
    5. 5.
      Loss of alveolar attachments → airway collapse

    Mnemonic: COPD Destruction — "PROM"

    • Protease excess
    • ROS accumulation
    • Oxidative stress
    • Metrix breakdown
    High-YieldNEET PG
    On NEET PG, when you see "oxidative stress" + "CD8+ T cells" + "progressive airway destruction" in a smoker, the answer is always protease-antiprotease imbalance.
    Why α₁-AT Deficiency Is Different

    In α₁-AT deficiency, there is a primary antiprotease deficiency (genetic), whereas in smoking-related COPD, the antiprotease system is functionally overwhelmed and inactivated by oxidative stress. Both converge on the same final pathway: unopposed protease activity.

    Practice similar questions

    Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.

    Start Practicing Free More Pathology Questions

    Join our NEET PG community

    Daily MCQs, study tips, and topper strategies on Telegram.

    Join on Telegram →